M2GEN, Microsoft to collaborate on bioinformatics solutions for oncology

Dewpoint Therapeutics and ConcertAI form drug development partnership

Dewpoint Therapeutics and ConcertAI announced the first phase of their Translational Oncology partnership, aligned around Dewpoint’s latest drug candidate, DPTX3186.

December 13, 2024

Vol.50 No.46

Drugs & Targets

Humana and Evolent expand partnership to enhance oncology care

Humana Inc. and Evolent Health Inc. announced an expansion of their strategic medical oncology partnership to modernize and streamline prior authorization processes to include radiation and surgical oncology services.

November 15, 2024

Vol.50 No.43

In Brief

OmniaBio opens commercial manufacturing facility in Canada, bringing cell and gene therapies to patients

OmniaBio Inc. announced the opening of a new North American cell and gene therapy manufacturing and artificial intelligence center of excellence, which is now Canada’s largest contract development and manufacturing organization facility dedicated to CGT.

October 25, 2024

Vol.50 No.40

In Brief

Alex Morozov named chief medical officer at Pi Health

Alex Morozov was named the first chief medical officer of Pi Health, an oncology clinical trial and research technology company.

August 09, 2024

Vol.50 No.32

Drugs & Targets

Shasqi, Johnson & Johnson expand existing research collaboration

Shasqi, Inc. and Johnson & Johnson Enterprise Innovation Inc. have expanded their ongoing research collaboration.

October 13, 2023

Vol.49 No.38

Drugs & Targets

Pierre Fabre Laboratories, Vernalis partner to advance cancer research

Pierre Fabre Laboratories and Vernalis, a fully owned subsidiary of HitGen Inc., established a long-term partnership to identify pre-clinical candidates against oncology targets.

September 29, 2023

Vol.49 No.36

M2GEN, Microsoft to collaborate on bioinformatics solutions for oncology

YOU MAY BE INTERESTED IN

Dewpoint Therapeutics and ConcertAI form drug development partnership

Humana and Evolent expand partnership to enhance oncology care

OmniaBio opens commercial manufacturing facility in Canada, bringing cell and gene therapies to patients

Alex Morozov named chief medical officer at Pi Health

Shasqi, Johnson & Johnson expand existing research collaboration

Pierre Fabre Laboratories, Vernalis partner to advance cancer research

Renew today!

Subscriber content

Never miss an issue!

Login